Arctic Bioscience Logo

Arctic Bioscience

Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.

ABS | OL

Overview

Corporate Details

ISIN(s):
NO0010859580
LEI:
549300Z2HW6I989Q2C78
Country:
Norway
Address:
Industrivegen 42, 6155 ØRSTA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Arctic Bioscience is a biotechnology company that develops, manufactures, and commercializes pharmaceutical and nutraceutical ingredients derived from marine membrane lipids. Leveraging over 30 years of experience, the company utilizes proprietary technology to extract bioactive compounds, such as high-DHA Omega-3 phospholipids, from sustainably sourced Norwegian herring roe. Its business is structured into two main segments: a nutraceutical division, which markets products under the Romega® brand, and a pharmaceutical division focused on developing novel therapies for autoimmune disorders. The company's approach is founded on extensive scientific research and a commitment to sustainable practices.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 12:04
Regulatory News Service
Arctic Bioscience - Protokoll fra ekstraordinær generalforsamling - Attachment:…
Norwegian 346.3 KB
2025-11-11 12:04
Regulatory News Service
Arctic Bioscience - Minutes of the Extraordinary General Meeting - Attachment: …
Norwegian 346.3 KB
2025-11-11 12:04
Post-Annual General Meeting Information
Arctic Bioscience - Protokoll fra ekstraordinær generalforsamling
Norwegian 1.6 KB
2025-11-11 12:04
Post-Annual General Meeting Information
Arctic Bioscience - Minutes of the Extraordinary General Meeting
English 1.6 KB
2025-11-10 07:00
Investor Presentation
Arctic Bioscience - Q3 2025 Operational update - Significant results on systemi…
English 4.1 MB
2025-11-10 07:00
Investor Presentation
Arctic Bioscience - 3. kvartal 2025 operasjonell oppdatering - Signifikante eff…
English 4.1 MB
2025-11-10 07:00
Earnings Release
Arctic Bioscience - Q3 2025 Operational update - Significant results on systemi…
English 9.8 KB
2025-11-10 07:00
Earnings Release
Arctic Bioscience - 3. kvartal 2025 operasjonell oppdatering - Signifikante eff…
Norwegian 10.0 KB
2025-11-07 08:00
Report Publication Announcement
Arctic Bioscience - Invitation to presentation of Q3 operational update and HeR…
English 2.1 KB
2025-11-07 08:00
Report Publication Announcement
Arctic Bioscience - Invitasjon til presentasjon av Q3 operasjonell oppdatering …
Norwegian 2.1 KB
2025-11-04 08:52
Regulatory News Service
Arctic Bioscience - Analyse av HeROPA-studien viser statistisk signifikante eff…
Norwegian 1.7 MB
2025-11-04 08:52
Regulatory News Service
Arctic Bioscience - Analysis on HeROPA study shows statistically significant ef…
English 1.7 MB
2025-11-04 08:52
Regulatory News Service
Arctic Bioscience - Analyse av HeROPA-studien viser statistisk signifikante eff…
Norwegian 5.3 KB
2025-11-04 08:52
Regulatory News Service
Arctic Bioscience - Analysis on HeROPA study shows statistically significant ef…
English 5.5 KB
2025-10-28 09:30
Pre-Annual General Meeting Information
Arctic Bioscience - Innkalling til ekstraordinær generalforsamling 11. november…
Norwegian 1.1 MB

Automate Your Workflow. Get a real-time feed of all Arctic Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Arctic Bioscience

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Arctic Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GRI Bio, Inc. Logo
Advancing NKT cell modulators for inflammatory, fibrotic, and autoimmune diseases.
United States of America
GRI
Grifols S.A. Logo
Leading producer of plasma-derived medicines for patients with rare and chronic diseases.
Spain
GRF
Grindeks Logo
Develops & manufactures pharmaceuticals for cardiovascular, CNS, cancer, and diabetes globally.
Latvia
GRD1R
GT Biopharma, Inc. Logo
Develops TriKE® immunotherapies engaging NK cells to treat hematologic and solid tumor cancers.
United States of America
GTBP
Guardant Health, Inc. Logo
Develops liquid biopsies for cancer detection, monitoring, and personalized treatment guidance.
United States of America
GH
Guard Therapeutics International AB Logo
Clinical-stage biotech developing drugs to prevent acute kidney injury during open-heart surgery.
Sweden
GUARD
Develops research antibodies and distributes scientific instruments for life science researchers.
South Korea
036180
GYRE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing novel drugs for liver fibrosis and pneumoconiosis.
United States of America
GYRE
Haleon PLC Logo
A global consumer healthcare leader providing trusted, science-backed OTC brands for everyday health.
United Kingdom
HLN
Halychpharm Logo
A pharmaceutical manufacturer of finished medicines and plant-derived phytochemical substances.
Ukraine
GFARM

Talk to a Data Expert

Have a question? We'll get back to you promptly.